-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 14, LANXESS released its financial report showing that the company's sales in the third quarter increased to 2.
185 billion euros from 1.
581 billion euros in the same period of the previous year, an increase of 38.
2%; EBITDA for the regular business amounted to €240 million, up 4.
8 percent
compared to €229 million in the prior-year quarter.
LANXESS said that in addition to the additives business, the consumer protection business segment performed well
.
The acquisition of the microbial control business of U.
S.
International Flavors and Fragrances was completed this year and Emerald in 2021
The acquisition of Kalama Chemical's business helped the segment to achieve good returns
.
Mutian Chang, Chairman of the Board of Management of LANXESS AG, said: "In the middle of this year, we once again strengthened our consumer protection business segment with the acquisition of the microbial control business
of American International Flavors & Fragrances.
However, we have seen weaker demand in some regions and an overall decline
in sales.
In the fourth quarter, the situation will be even more severe
with further increases in energy prices and the threat of recession.
”
